JAZZ

JAZZ

USD

Jazz Pharmaceuticals plc Common Stock (Ireland)

$137.820+1.270 (0.930%)

Reaalajas hind

Healthcare
Biotehnoloogia
Iirimaa

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$136.550

Kõrge

$139.065

Madal

$136.000

Maht

0.96M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

8.4B

Tööstusharu

Biotehnoloogia

Riik

Ireland

Kauplemisstatistika

Keskmine maht

0.74M

Börs

NMS

Valuuta

USD

52 nädala vahemik

Madal $95.49Praegune $137.820Kõrge $148.06

Seotud uudised

PR Newswire

Jazz Pharmaceuticals Appoints Ted W. Love, M.D., to its Board of Directors

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Ted W. Love, M.D., has been appointed to the Company's Board of Directors, effective...

Vaata rohkem
Jazz Pharmaceuticals Appoints Ted W. Love, M.D., to its Board of Directors
Analyst Upgrades

JP Morgan Maintains Overweight on Jazz Pharmaceuticals, Lowers Price Target to $199

JP Morgan analyst Jessica Fye maintains Jazz Pharmaceuticals with a Overweight and lowers the price target from $204 to $199.

Vaata rohkem
JP Morgan Maintains Overweight on Jazz Pharmaceuticals, Lowers Price Target to $199
PR Newswire

Jazz Pharmaceuticals to Report Third Quarter Financial Results on November 5, 2025

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that it will report its 2025 third quarter financial results on Wednesday, November 5, 2025,...

Vaata rohkem
Jazz Pharmaceuticals to Report Third Quarter Financial Results on November 5, 2025

Püsi kursis

Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.